Latest News for: intravitreal
Edit
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis (ANI Pharmaceuticals Inc)
Public Technologies 13 Jul 2026
The most common adverse events seen in SYNCHRONICITY were consistent with prior trials of the fluocinolone acetonide intravitreal implant ... About ILUVIEN (fluocinolone acetonide intravitreal implant).
- 1